Name | 7-Hydroxyisoflavone |
Synonyms | 7-Hydroxyisoflavone 7-Hydroxy Isoflavone Ipriflavone impurity B 7-Hydroxy-3-phenylchromone 7-hydroxy-3-phenyl-4-chromenone 7-hydroxy-3-phenyl-4H-chromen-4-one Isoflavone, 7-hydroxy- (6CI,7CI,8CI) 7-Hydroxy-3-phenyl-4H-1-benzopyran-4-one 3-Phenyl-7-hydroxy-4H-1-benzopyran-4-one 4H-1-Benzopyran-4-one, 7-hydroxy-3-phenyl- 7-Hydroxy-3-phenyl-4H-chromen-4-one AldrichCPR |
CAS | 13057-72-2 |
InChI | InChI=1/C15H10O3/c16-11-6-7-12-14(8-11)18-9-13(15(12)17)10-4-2-1-3-5-10/h1-9,16H |
Molecular Formula | C15H10O3 |
Molar Mass | 238.24 |
Density | 1.340±0.06 g/cm3(Predicted) |
Melting Point | 214.0 to 218.0 °C |
Boling Point | 450.1±45.0 °C(Predicted) |
Flash Point | 176.3°C |
Vapor Presure | 1.02E-08mmHg at 25°C |
Appearance | White powder |
Color | White to Almost white |
Maximum wavelength(λmax) | ['296nm(MeOH)(lit.)'] |
pKa | 6.98±0.20(Predicted) |
Storage Condition | 2-8℃ |
Refractive Index | 1.666 |
MDL | MFCD00017701 |
Hazard Symbols | Xn - Harmful |
Risk Codes | R22 - Harmful if swallowed R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
RTECS | DJ3100255 |
HS Code | 29145090 |
Hazard Class | IRRITANT |
Reference Show more | 1. [IF=3.738] Selma Houchi et al."Investigation of common chemical components and inhibitory effect on GES-type β-lactamase (GES22) in methanolic extracts of Algerian seaweeds."Microb Pathogenesis. 2019 Jan;126:56 |
Application of | 7-hydroxyisoflavone different crystalline substances as active ingredients to prepare various preparations and pharmaceutical compositions developed, in the prevention and treatment of cardiovascular and cerebrovascular diseases, Osteoporosis, inflammation, metabolic diseases and other diseases play an advantageous clinical therapeutic role; it is found that the crystal form will affect the absorption rate of the active ingredients of the solid drug in the organism, enhance or reduce the blood drug concentration in the organism, and thus affect the therapeutic effect of the drug in clinical practice. |